EOM Pharmaceuticals, Inc
EOM Pharmaceuticals, based in Montvale, NJ, is a pharmaceutical company dedicated to rescuing, repairing, and restoring health in patients suffering from debilitating and life-threatening diseases. They focus on developing novel drugs with the potential to transform therapeutic paradigms and improve the quality of life for patients. Their lead drug candidate, EOM613, is a peptide-nucleic acid-based immune regulating agent that acts on both pro-inflammatory and anti-inflammatory cytokines, offering potential therapeutic utility in treating various acute and chronic inflammatory conditions.
EOM Pharmaceuticals is also developing EOM147, an investigational aminosterol with a unique intracellular mechanism for the treatment of retinal diseases. This compound affects multiple angiogenic growth factors and is administered as an eye drop, representing a potential breakthrough that eliminates the need for intraocular injections. With a relentless focus on science and a commitment to supporting each other and humankind, EOM Pharmaceuticals is dedicated to making a significant impact in the field of medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
